Shanghai Best-Link Bioscience LLC was founded in 2021 and is a high-tech enterprise engaged in innovative drug research and development. Best-Link focuses on the development of novel nano-conjugate drugs and precise nano-drug delivery platforms based on advanced conjugation technology and nanotechnology to develop innovative drugs for precision cancer treatment and tumor immunotherapy. Best-Link adheres to the concept of "Benefiting the people and leading the future", and is committed to developing innovative drugs with better therapeutic effects, less toxic side effects, and better compliance.